Over medication in people with intellectual disabilities and autism spectrum disorder: A literature review of staff perceptions of psychotropic medication
{"title":"Over medication in people with intellectual disabilities and autism spectrum disorder: A literature review of staff perceptions of psychotropic medication","authors":"Millie Crouch, L. Haggar","doi":"10.53841/bpsfpid.2021.19.2.39","DOIUrl":null,"url":null,"abstract":"• Research into the understanding of medication in staff that support people with intellectual disabilities (ID) and Autism Spectrum Disorder (ASD) is very limited.• Existing research suggests that staff require more training around medication and need more involvement in medication decisions.• Training staff and involving them in medication decisions would help to improve the quality of life of people with ID and ASD, with side effects of medication identified and addressed more quickly.","PeriodicalId":302131,"journal":{"name":"FPID Bulletin: The Bulletin of the Faculty for People with Intellectual Disabilities","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"FPID Bulletin: The Bulletin of the Faculty for People with Intellectual Disabilities","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53841/bpsfpid.2021.19.2.39","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
• Research into the understanding of medication in staff that support people with intellectual disabilities (ID) and Autism Spectrum Disorder (ASD) is very limited.• Existing research suggests that staff require more training around medication and need more involvement in medication decisions.• Training staff and involving them in medication decisions would help to improve the quality of life of people with ID and ASD, with side effects of medication identified and addressed more quickly.